GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelira Therapeutics Ltd (ASX:ZLD) » Definitions » Other Assets for Insurance Companies

Zelira Therapeutics (ASX:ZLD) Other Assets for Insurance Companies


View and export this data going back to 2003. Start your Free Trial

What is Zelira Therapeutics Other Assets for Insurance Companies?

Other Assets for Insurance Companies only applies to insurance companies.


Zelira Therapeutics (ASX:ZLD) Business Description

Industry
Traded in Other Exchanges
Address
101 St George’s Terrace, Level 3, Perth, WA, AUS, 6000
Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.